Telmisartan, Amlodipine and Combination in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

November 30, 2010

Conditions
Healthy
Interventions
DRUG

amlodipine/telmisartan/combination

patient would take amlodipine(5mg)/telmisartan(80mg)/combination(T80+A5mg) single dose in random order, and each dosage will be separated in 21 days interval.

Trial Locations (1)

Unknown

1235.30.86001 Boehringer Ingelheim Investigational Site, Shanghai

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY